Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sharon Taub, Amir Krivoy, Eromona Whiskey & Sukhi S. Shergill. (2022) New approaches to antipsychotic medication adherence – safety, tolerability and acceptability. Expert Opinion on Drug Safety 21:4, pages 517-524.
Read now
Read now
Articles from other publishers (6)
Wisam Al Jumaili & Shailesh Jain. (2022) Role of asenapine as an augmenter for treatment-resistant schizophrenia. Psychiatry Research Case Reports 1:2, pages 100019.
Crossref
Crossref
Ana P. Araujo de Oliveira, Victoria C. Romero Colmenares, Renata Diniz, Jennifer T. J. Freitas, Clara M. da Cruz, Eduardo B. Lages, Lucas A. M. Ferreira, Rafael P. Vieira & Heloisa Beraldo. (2022) Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates. ACS Omega 7:14, pages 11678-11687.
Crossref
Crossref
Mehak Pahwa, Ahmad Sleem, Omar H. Elsayed, Megan Elizabeth Good & Rif S. El-Mallakh. (2021) New Antipsychotic Medications in the Last Decade. Current Psychiatry Reports 23:12.
Crossref
Crossref
Jonathan M. Meyer & Stephen M. Stahl. 2021. The Clinical Use of Antipsychotic Plasma Levels. The Clinical Use of Antipsychotic Plasma Levels
337
371
.
Young-A Heo. (2021) Asenapine transdermal delivery system (Secuado®) in schizophrenia: a profile of its use in the USA. Drugs & Therapy Perspectives 37:6, pages 229-235.
Crossref
Crossref
Katsumi Suzuki, Mariacristina Castelli, Marina Komaroff, Brittney Starling, Takaaki Terahara & Leslie Citrome. (2021) Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070). Journal of Clinical Psychopharmacology 41:3, pages 286-294.
Crossref
Crossref